In this issue:
Defining lines of therapy in haematological malignancies
Management of bispecific antibody toxicities
MRD in haematopoietic neoplasms
Evolution of real-world front-line treatment patterns in multiple myeloma
Psychometric properties of PROMS for HRQoL in MM
PBS changes
Ciltacabtagene autoleucel (Carvykti) now available
Managing MM in patients on clozapine therapy
Registrations now open for the National Medicines Symposium 2026
Conferences & Workshops
Please login below to download this issue (PDF)